BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20817887)

  • 1. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
    Wu Z; Liu D; Sui Y
    J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent hit series hidden in high-throughput screening data.
    Varin T; Didiot MC; Parker CN; Schuffenhauer A
    J Med Chem; 2012 Feb; 55(3):1161-70. PubMed ID: 22185196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays.
    Zhang XD
    J Biomol Screen; 2007 Aug; 12(5):645-55. PubMed ID: 17517904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical practice in high-throughput screening data analysis.
    Malo N; Hanley JA; Cerquozzi S; Pelletier J; Nadon R
    Nat Biotechnol; 2006 Feb; 24(2):167-75. PubMed ID: 16465162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.
    Zhang XD; Yang XC; Chung N; Gates A; Stec E; Kunapuli P; Holder DJ; Ferrer M; Espeseth AS
    Pharmacogenomics; 2006 Apr; 7(3):299-309. PubMed ID: 16610941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Median absolute deviation to improve hit selection for genome-scale RNAi screens.
    Chung N; Zhang XD; Kreamer A; Locco L; Kuan PF; Bartz S; Linsley PS; Ferrer M; Strulovici B
    J Biomol Screen; 2008 Feb; 13(2):149-58. PubMed ID: 18216396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved statistical methods for hit selection in high-throughput screening.
    Brideau C; Gunter B; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):634-47. PubMed ID: 14711389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the primary screening efficiency by multiple replicate testing: a quantitative analysis of hit confirmation and false screening results of a biochemical assay.
    Zhang JH; Wu X; Sills MA
    J Biomol Screen; 2005 Oct; 10(7):695-704. PubMed ID: 16129776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for identifying compounds that specifically target translation.
    Brandi L; Fabbretti A; Milon P; Carotti M; Pon CL; Gualerzi CO
    Methods Enzymol; 2007; 431():229-67. PubMed ID: 17923238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
    Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
    J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Error rates and powers in genome-scale RNAi screens.
    Zhang XD; Marine SD; Ferrer M
    J Biomol Screen; 2009 Mar; 14(3):230-8. PubMed ID: 19211781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.